Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker

Tech Insider : Business
Red pills with $100 bills wrapped around them.
Chris Roop, head of M&A for the Americas at investment bank Jefferies, said Big Pharma will be looking for new drugs to boost growth in 2025.

GP Kidd/Getty Images

Meet Jeff Smith, the hedge-fund investor taking on Pfizer

Tech Insider
Jeff Smith stands at a podium in 2015
Jeff Smith stands at a podium in 2015

: Heidi Gutman/CNBC/NBCU Photo Bank

Activist investor Starboard has informed Pfizer it has taken a stake

Tech Insider
Pfizer
An activist investor has taken a stake in Pfizer.

Kamil Krzaczynski/AFP via Getty Images

Joe Biden is taking Paxlovid, even though doctors know it doesn't really work

Tech Insider
joe biden rolling up sleeve for booster shot
He's vaxxed. He's boosted. Will Paxlovid help? Probably not.

Anna Moneymaker/Getty Images

Joe Biden Trolls Conspiracy Theorists Who Think He Rigged the Super Bowl

Gizmodo

President Joe Biden has a message for the right-wing conspiracy theorists who were convinced he was rigging the Super Bowl in favor of Taylor Swift’s boyfriend: The plan went off without a hitch.

Read more...

Vaccine Life Hack: Use Both Arms

Gizmodo

Here’s one weird trick for making the most out of your next two-dose vaccine: get a shot in both arms. A recent study found evidence that a two-arm approach can noticeably, if modestly, improve the body’s immune response to covid-19 compared to two shots in the same arm. More research will be needed to confirm whether…

Read more...

Pharma giants are hiking prices on over 500 drugs for 2024, report says

Tech Insider
Sanofi
Employees work for maintenance in the purification and dispensing unit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Neuville-sur-Saone, near Lyon March 14, 2014.

Robert Pratta/Reuters

Pfizer CEO slams Harvard, MIT, and UPenn's presidents: 'One of the most despicable moments in the history of US academia'

Tech Insider
Albert Bourla (left) and Claudine Gay (right).
Pfizer chairman and CEO Albert Bourla (left) and Harvard president Claudine Gay (right).

Drew Angerer via Getty Images; Kevin Dietsch via Getty Images

A biotech firm founded by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that Pfizer gave it for free

Tech Insider
Vivek Ramaswamy
Conservative entrepreneur Vivek Ramaswamy

Scott Olson/Getty Images

Covid-19 Might Trigger a Rare Paralyzing Condition

Gizmodo

New research links the rare neurological condition Guillain-Barré syndrome to covid-19. The study tracked millions of people in Israel, finding that those with a recent history of covid-19 infection were noticeably more likely to develop Guillain-Barré than those without one. Conversely, covid-19 vaccination appeared…

Read more...

Subscribe to pfizer